Kidney Organoids

What’s Inside the Brochure?

Comprehensive Kidney Organoid Construction and Differentiation

An outline of our robust protocols for generating kidney organoids that mirror the cellular complexity and architecture of the kidney, providing a reproducible system for experimental manipulation.

Disease-Relevant Organoid Models

A summary of well-characterized models, including fibrosis, high-fat diet–induced injury, diabetic nephropathy, and polycystic kidney disease (PKD). Each model captures distinct pathological hallmarks, such as extracellular matrix deposition, lipotoxicity, glomerular and tubular damage, and inflammatory cascades.

Multidimensional Readouts and Assays

A description of the analytical toolkit available for evaluating organoid phenotypes, including histopathological staining, immunofluorescence, and molecular expression profiling at the mRNA level, all tailored to assess disease progression and therapeutic responses.

Nephrotoxicity Evaluation Platform

An introduction to our standardized workflow for assessing compound-induced kidney injury, enabling predictive safety profiling early in the drug discovery pipeline.

Case Study Highlights

Insights into representative applications, including TGF-β–driven fibrosis, palmitic acid–induced lipotoxicity, high glucose–mediated diabetic nephropathy, and screening of candidate compounds in PKD organoids, illustrating the platform’s versatility and translational potential.

Download the full brochure to discover how Ace Therapeutics’ kidney organoid platform can accelerate your nephrology research and therapeutic development.

You might be interested in...